Transdiagnostic treatment of emotional disorders in people with multiple sclerosis: randomized controlled trial

BMC Psychology

Table 1 Demographic characteristics of the sample (N = 70)

Item Characteristic	Value	Test	p
MS duration, n (%)
to 3 years	39 (28.2)	χ² = 0.92	.396
3 to 7 years	31 (44.75)
Gender, n (%)
Women	43 (63.4)	χ² = 3.65	.056
Man	27 (38.6)
Education, n (%)
Primary education	12 (17.1)	χ² = 30.22	< .001
Higher education	58 (82.9)
Marital, n (%)
Single	28 (40)	χ² = 2.80	.091
In relationship	42 (60)
Principal diagnosis SCID
Depressive disorder, n (%)
MDD	34 (48.6)
Dysthymia	5 (7.1)
Anxiety disorder, n (%)
GAD	22 (31.4)
SAD	9 (12.9)
Continues variables
Age, M (SD), y	35.13 (5.28)	t(68) = 1.01	.321
MS duration, M (SD), y	3.31 (1.37)	t(68) = 1.03	.304
PANAS-PA, M ((SD)	26.00 (3.75)	t(68) = 1.55	.122
PANAS-NA, M ((SD)	27.42 (2.72)	t(68) = − 0.6	.148
PSWQ, M (SD)	47.55 (9.46)	t(68) = − 1.23	.221
HADS-A, M (SD)	12.43 (1.37)	t(68) = − 1.89	.059
HADS-D, M ((SD)	12.84 (1.63)	t(68) = − 1.24	.214
DERS, M ((SD)	110.14 (12.17)	t(68) = − 1.50	.132

n frequency, y years, SCID-I–IV structured clinical interview for DSM-IV axis i disorders, MDD major depressive disorder, GAD generalized anxiety disorder, SAD social anxiety disorder, t independent t test, SD standard deviation, PANAS-PA positive and negative affect schedule-positive affect, PANAS-NA positive and negative affect schedule-negative affect, HADS-A the hospital anxiety and depression scale-Anxiety, HADS-D the hospital anxiety and depression scale-depression, PSWQ Penn State Worry Questionnaire, DERS difficulties in emotion regulation scale

ISSN: 2050-7283